Trevi Therapeutics (TRVI) Total Debt (2020 - 2023)
Trevi Therapeutics (TRVI) posted quarterly Total Debt of $7.5 million for Q1 2023, down 46.77% year-over-year from $14.1 million in Q1 2022, and down 18.24% quarter-over-quarter from $9.2 million in Q4 2022.
Trevi Therapeutics (TRVI) Total Debt (2020 - 2023) Analysis & Trends
Trevi Therapeutics' Total Debt history runs 4 years deep, the most recent figure standing at $7.5 million for Q1 2023.
- In Q1 2023, Total Debt fell 46.77% year-over-year to $7.5 million; the TTM figure through Mar 2023 stood at $7.5 million (down 46.77% YoY), while the FY2022 annual figure was $9.2 million, down 36.82% from the prior year.
- Total Debt for Q1 2023 stood at $7.5 million, down from $9.2 million in the prior quarter.
- The five-year high for Total Debt was $14.5 million in Q4 2021, with the low at $7.5 million in Q1 2023.
- The 4-year median for Total Debt is $14.0 million (2020), against an average of $12.6 million.
- The sharpest annual moves came in 2021 and 2023: Total Debt increased 3.84% in 2021, then plunged 46.77% in 2023.
- Trevi Therapeutics' Total Debt stood at $14.0 million in 2020, then climbed by 3.81% to $14.5 million in 2021, then tumbled by 36.82% to $9.2 million in 2022, then dropped by 18.24% to $7.5 million in 2023.
- Business Quant data shows TRVI's Total Debt at $7.5 million in Q1 2023, $9.2 million in Q4 2022, and $10.8 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 7.48 Mn |
| Dec 31, 2022 | 9.15 Mn |
| Sep 30, 2022 | 10.80 Mn |
| Jun 30, 2022 | 12.43 Mn |
| Mar 31, 2022 | 14.06 Mn |
| Dec 31, 2021 | 14.49 Mn |
| Sep 30, 2021 | 14.33 Mn |
| Jun 30, 2021 | 14.25 Mn |
| Mar 31, 2021 | 14.10 Mn |
| Dec 31, 2020 | 13.95 Mn |
| Sep 30, 2020 | 13.80 Mn |